India’s NCB Rolls Out ‘Operation WIPE’ to Crush Online Pharmaceutical Drug Networks

“Kochi, July 21 2026 –” the headline read, but the story behind it unfolds across continents. India’s Narcotics Control Bureau (NCB) has kicked off what it calls Operation WIPE – short for Web‑based Illicit Activities Prevention & Enforcement – a mouthful that belies a very concrete mission: to hunt down and shut down the digital marketplaces peddling prescription medicines that are legally banned under the NDPS Act.

It sounds like something out of a thriller, yet the numbers the agency quoted are starkly real. NCB officials say they have identified 122 pharmaceutical products being misused, of which 58 are expressly prohibited by the Narcotic Drugs and Psychotropic Substances Act, and four fall under the category of controlled narcotic substances. In 2024 alone the bureau seized roughly 4.69 crore (about 46.9 million) tablets – a jump that is nearly three times what was reported in the previous year.

The crackdown isn’t limited to a few shady sellers in a back‑alley. Earlier this year NCB dismantled a sprawling syndicate that ran an illegal call centre out of Uduvi, Karnataka. That operation was not just feeding local addicts; it was shipping restricted medicines across Asia, North America, Europe and even as far as Australia, using business‑to‑business platforms that most of us never think of as drug‑distribution channels.

What makes Operation WIPE stand out is its collaborative DNA. The NCB is leaning on intelligence from the International Narcotics Control Board’s (INCB) secure platform, and it has the backing of the U.S. Drug Enforcement Administration (DEA). In addition, other foreign law‑enforcement agencies have been roped in, turning what might have been a domestic clean‑up into a truly global pursuit.

For the everyday internet user, the change will be subtle but important. Websites that once listed “legitimate” medical supplies will now face stricter scrutiny, and any attempt to market these controlled substances online could trigger a rapid, coordinated response from multiple agencies. The message is clear: the digital age does not grant a free pass to break drug laws, and the net is tightening.

While the NCB has not named any individual officers or disclosed the full scope of ongoing investigations, the sheer volume of tablets seized and the breadth of international cooperation suggest this is only the beginning. If successful, Operation WIPE could set a precedent for how nations tackle the growing problem of online drug commerce, blending technology, law‑enforcement expertise, and a firm resolve to protect public health.